Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia [4]

Rheumatology

Volumn 44, Issue 3, 2005, Pages 406-

  Catuogno, Manuela ^a   Rezai, S ^a   Priori, R ^a   Magrini, L ^a   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; BETAMETHASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; PEGINTERFERON; PREDNISONE; RHEUMATOID FACTOR; RIBAVIRIN; RITUXIMAB; VIRUS ANTIBODY;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBODY DETECTION; ARTHRALGIA; BLOOD ANALYSIS; CASE REPORT; CRYOGLOBULINEMIA; CUSHINGOID SYNDROME; DRUG MECHANISM; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; FEVER; GENOTYPE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; LETTER; LEUKOPENIA; LIVER BIOPSY; OSTEOPOROSIS; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; SERUM SICKNESS; SKIN ULCER; TREATMENT REFUSAL; URTICARIA; VIRUS REPLICATION;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; SERUM SICKNESS;

EID: 14944374052     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh470     Document Type: Letter

References (6)

1. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon-α with an anti-CD20. Blood 2003;101: 3818-26.
2. Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003;101:3827-34.
3. Grillo-Lopez AJ, White CA, Varns C et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 1999;26(S14):66-73.
4. D'Arcy CA, Mannick M. Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum 2001;44:1717-8.
5. Herishanu Y. Rituximab-induced serum sickness. Am J Hematol 2002;70:329.
6. Hellerstedt B, Ahmed A. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol 2003;14:1792.